How to Support Participants in Urogenital and Prostate Clinical Trials: A Qualitative Perspective.

IF 3.5 2区 医学 Q2 ONCOLOGY
Natasha A Roberts, Ian D Davis, David Wyld, Jeffrey Goh, Maxwell Thompson, Craig Gedye, Haryana M Dhillon
{"title":"How to Support Participants in Urogenital and Prostate Clinical Trials: A Qualitative Perspective.","authors":"Natasha A Roberts, Ian D Davis, David Wyld, Jeffrey Goh, Maxwell Thompson, Craig Gedye, Haryana M Dhillon","doi":"10.1002/pon.70214","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Clinical trials are fundamental to improving cancer treatment and clinical outcomes. Whilst clinical trials offer treatment options to affected individuals, less is known about how to best support those who participate.</p><p><strong>Aim: </strong>To explore the experiences of participants in urogenital and prostate cancer clinical trials to identify opportunities to improve care for this cohort of patients.</p><p><strong>Methods: </strong>This qualitative study was conducted in Australian hospitals. Participants were included if they had consented to participate in an Australian collaborative investigator led clinical trial for prostate or other urogenital cancer. Semi-structured interviews with participants were completed by telephone. Using verbatim transcriptions, their experiences relative to key stages of a clinical trial were analysed using a Framework Method. Findings were interpreted to develop key recommendations for use by investigators developing a clinical trial.</p><p><strong>Results: </strong>22 people consented and participated in interviews. They came from rural, regional, and metropolitan areas across Australia. Participants were being treated for advanced uro-genital and prostate cancers. Across interviews, participants spoke about their supportive care needs and how they valued their relationships with the multi-disciplinary research team and the clinical oncology and urology teams. There was variation in participant needs according to the stage of the clinical trial. Despite times of uncertainty, it was reported clinical trial participation was meaningful. Receiving information about overall findings of the clinical trial was important to participants allowing them to understand the impact of their contribution.</p><p><strong>Conclusion: </strong>Understanding the experiences of clinical trial participants can improve the design of trial protocol processes and procedures. Participants want to stay connected with their clinical trial.</p>","PeriodicalId":20779,"journal":{"name":"Psycho‐Oncology","volume":"34 7","pages":"e70214"},"PeriodicalIF":3.5000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12260335/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psycho‐Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pon.70214","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Clinical trials are fundamental to improving cancer treatment and clinical outcomes. Whilst clinical trials offer treatment options to affected individuals, less is known about how to best support those who participate.

Aim: To explore the experiences of participants in urogenital and prostate cancer clinical trials to identify opportunities to improve care for this cohort of patients.

Methods: This qualitative study was conducted in Australian hospitals. Participants were included if they had consented to participate in an Australian collaborative investigator led clinical trial for prostate or other urogenital cancer. Semi-structured interviews with participants were completed by telephone. Using verbatim transcriptions, their experiences relative to key stages of a clinical trial were analysed using a Framework Method. Findings were interpreted to develop key recommendations for use by investigators developing a clinical trial.

Results: 22 people consented and participated in interviews. They came from rural, regional, and metropolitan areas across Australia. Participants were being treated for advanced uro-genital and prostate cancers. Across interviews, participants spoke about their supportive care needs and how they valued their relationships with the multi-disciplinary research team and the clinical oncology and urology teams. There was variation in participant needs according to the stage of the clinical trial. Despite times of uncertainty, it was reported clinical trial participation was meaningful. Receiving information about overall findings of the clinical trial was important to participants allowing them to understand the impact of their contribution.

Conclusion: Understanding the experiences of clinical trial participants can improve the design of trial protocol processes and procedures. Participants want to stay connected with their clinical trial.

Abstract Image

如何支持参与者在泌尿生殖和前列腺临床试验:定性的观点。
背景:临床试验是改善癌症治疗和临床结果的基础。虽然临床试验为受影响的个人提供了治疗选择,但人们对如何最好地支持参与者知之甚少。目的:探讨泌尿生殖系统和前列腺癌临床试验参与者的经验,以确定改善这一队列患者护理的机会。方法:本定性研究在澳大利亚医院进行。如果参与者同意参加澳大利亚合作研究者领导的前列腺癌或其他泌尿生殖系统癌的临床试验,他们就被包括在内。对参与者的半结构化访谈是通过电话完成的。使用逐字转录,他们的经验相对于临床试验的关键阶段进行分析,使用框架方法。研究结果被解释为开发临床试验的研究人员使用的关键建议。结果:22人同意并参与访谈。他们来自澳大利亚各地的农村、地区和大都市。参与者正在接受晚期泌尿生殖和前列腺癌的治疗。在访谈中,参与者谈到了他们的支持性护理需求,以及他们如何重视与多学科研究团队、临床肿瘤学和泌尿学团队的关系。根据临床试验的阶段,参与者的需求有所不同。尽管存在不确定性,但据报道,参与临床试验是有意义的。获得有关临床试验总体结果的信息对参与者很重要,使他们能够了解他们的贡献的影响。结论:了解临床试验参与者的经验可以改进试验方案流程和程序的设计。参与者希望与他们的临床试验保持联系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Psycho‐Oncology
Psycho‐Oncology 医学-心理学
CiteScore
6.30
自引率
8.30%
发文量
220
审稿时长
3-8 weeks
期刊介绍: Psycho-Oncology is concerned with the psychological, social, behavioral, and ethical aspects of cancer. This subspeciality addresses the two major psychological dimensions of cancer: the psychological responses of patients to cancer at all stages of the disease, and that of their families and caretakers; and the psychological, behavioral and social factors that may influence the disease process. Psycho-oncology is an area of multi-disciplinary interest and has boundaries with the major specialities in oncology: the clinical disciplines (surgery, medicine, pediatrics, radiotherapy), epidemiology, immunology, endocrinology, biology, pathology, bioethics, palliative care, rehabilitation medicine, clinical trials research and decision making, as well as psychiatry and psychology. This international journal is published twelve times a year and will consider contributions to research of clinical and theoretical interest. Topics covered are wide-ranging and relate to the psychosocial aspects of cancer and AIDS-related tumors, including: epidemiology, quality of life, palliative and supportive care, psychiatry, psychology, sociology, social work, nursing and educational issues. Special reviews are offered from time to time. There is a section reviewing recently published books. A society news section is available for the dissemination of information relating to meetings, conferences and other society-related topics. Summary proceedings of important national and international symposia falling within the aims of the journal are presented.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信